Crinetics Pharmaceuticals Inc (CRNX)
57.00
+0.93
(+1.66%)
USD |
NASDAQ |
Nov 21, 16:00
57.00
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Enterprise Value: 4.337B for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.337B |
| November 19, 2024 | 4.254B |
| November 18, 2024 | 4.117B |
| November 15, 2024 | 4.212B |
| November 14, 2024 | 4.670B |
| November 13, 2024 | 4.601B |
| November 12, 2024 | 4.588B |
| November 11, 2024 | 4.703B |
| November 08, 2024 | 4.766B |
| November 07, 2024 | 4.660B |
| November 06, 2024 | 4.600B |
| November 05, 2024 | 4.476B |
| November 04, 2024 | 4.384B |
| November 01, 2024 | 4.372B |
| October 31, 2024 | 4.305B |
| October 30, 2024 | 4.286B |
| October 29, 2024 | 4.332B |
| October 28, 2024 | 4.415B |
| October 25, 2024 | 4.489B |
| October 24, 2024 | 4.561B |
| October 23, 2024 | 4.530B |
| October 22, 2024 | 4.642B |
| October 21, 2024 | 4.558B |
| October 18, 2024 | 4.594B |
| October 17, 2024 | 4.578B |
| Date | Value |
|---|---|
| October 16, 2024 | 4.573B |
| October 15, 2024 | 4.456B |
| October 14, 2024 | 4.041B |
| October 11, 2024 | 4.044B |
| October 10, 2024 | 3.919B |
| October 09, 2024 | 3.236B |
| October 08, 2024 | 3.317B |
| October 07, 2024 | 3.322B |
| October 04, 2024 | 3.433B |
| October 03, 2024 | 3.403B |
| October 02, 2024 | 3.504B |
| October 01, 2024 | 3.335B |
| September 30, 2024 | 3.268B |
| September 27, 2024 | 3.199B |
| September 26, 2024 | 3.185B |
| September 25, 2024 | 3.175B |
| September 24, 2024 | 3.124B |
| September 23, 2024 | 3.172B |
| September 20, 2024 | 3.391B |
| September 19, 2024 | 3.449B |
| September 18, 2024 | 3.361B |
| September 17, 2024 | 3.378B |
| September 16, 2024 | 3.454B |
| September 13, 2024 | 3.443B |
| September 12, 2024 | 3.237B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
164.62M
Minimum
Mar 16 2020
4.766B
Maximum
Nov 08 2024
1.060B
Average
630.72M
Median
Enterprise Value Benchmarks
| Clearside Biomedical Inc | 56.04M |
| Biomea Fusion Inc | 139.63M |
| NovaBay Pharmaceuticals Inc | 2.745M |
| Palatin Technologies Inc | 15.49M |
| iBio Inc | 9.932M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -76.83M |
| Total Expenses (Quarterly) | 87.80M |
| EPS Diluted (Quarterly) | -0.96 |
| Earnings Yield | -6.54% |
| Normalized Earnings Yield | -6.632 |